KCAS Bio is proud to announce our attendance at the Paris Saclay Cancer Cluster (PSCC) Summer Science Summit, taking place in Villejuif, France, on June 24, 2026. The Paris-Saclay Cancer Cluster (PSCC) will host a highly exclusive gathering in immuno-oncology in France.
On this summer day, a constellation of the world’s most influential immunologists — including a Nobel Laureate and the pioneers who transformed immune checkpoint therapy — will share one stage at Campus Grand Parc in Villejuif.
These are the scientists who decoded immune checkpoints, redefined tissue-resident immunity, reshaped myeloid biology, and opened entirely new therapeutic frontiers in cancer.
Supporting Oncology Drug Development
KCAS Bio supports oncology drug development with bioanalytical services across preclinical and clinical stages, including emerging modalities such as antibody–drug conjugates, cell and gene therapies, bispecific antibodies, and targeted protein degraders. Our expertise in pharmacokinetics, biomarkers, immunogenicity, and advanced flow cytometry supports mechanism-of-action studies, efficacy evaluation, and patient stratification.
Connect with KCAS Bio in Villejuif
We invite you to connect with KCAS Bio at the Summer Science Summit. Let’s discuss how our bioanalytical expertise can support your research and development initiatives. Whether you are exploring biomarkers, optimizing therapeutic approaches, or advancing to clinical trials, KCAS Bio is here to help you achieve your objectives. Contact us today to schedule a meeting during the conference. Together, we can drive innovation and make a lasting impact on the lives of patients worldwide.
Contact us to schedule a meeting.